A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome

Karin Boslooper, Peter Joosten, Nic J. G. M. Veeger, Robby Kibbelaar, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages2
Issue number21
Publication statusPublished - 16-Nov-2012
Event54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - Atlanta, Gabon
Duration: 8-Dec-201211-Dec-2012

Cite this